Luxembourg / London / New York / Boston / Paris – Following Astorg’s recent take-private of Hamilton Thorne, and simultaneous acquisition of Cook Medical’s Reproductive Health business (“Cook Medical RH”), the newly combined global leader in assisted reproductive technology (ART) has signed a definitive agreement to acquire FUJIFILM Irvine Scientific’s Medical Media Business (“Irvine Scientific MBU”) from FUJIFILM Irvine Scientific. FUJIFILM Irvine Scientific MBU provides products including culture and vitrification media for in-vitro fertilization (IVF), infertility research, and cytogenetic analysis. Astorg is now bringing the three businesses together creating a new global leading ART MedTech company with a new brand identity for the combined businesses being rolled out this year.
This strategic combination will provide fertility clinics and IVF laboratories with a comprehensive portfolio of high-quality, innovative products designed to enhance outcomes and increase accessibility to fertility treatments worldwide.
Judith Charpentier, Co-Head of Flagship Fund and Head of Healthcare, Astorg, commented: “This strategic add-on acquisition of a leading portfolio of ART media further strengthens the combined company’s ability to support fertility professionals, clinics, laboratories, and patients by delivering advanced solutions that improve fertility outcomes.
“With the combined business, we stand out as a global category leader driven by innovation and supported by high quality products”, continued Olivier Lieven, Partner, and Tobias Nordblom, Managing Director, Astorg.
Wil Boren, CEO of the combined company added: “We look forward to partnering with the FUJIFILM Irvine Scientific Medical Media Business leadership team and all employees to create a global ART leader together with Hamilton Thorne and Cook Medical’s Reproductive Health business, building on our long-standing commitment to the ART space and strong customer focus.”
Tim Mullane, President, FUJIFILM Irvine Scientific, commented: “This move allows for continued focus on our life sciences businesses within Fujifilm, and for the MBU to thrive under Astorg, who has demonstrated a strong commitment to building capabilities to support the IVF market. We will work closely with Astorg and key stakeholders to ensure a smooth transition of FUJIFILM Irvine Scientific MBU and seamless support for global IVF customers.”
Astorg, FUJIFILM Irvine Scientific, and the management of the combined businesses led by Wil Boren are working actively on integration plans including significant additional investment by Astorg focused on offering fertility clinics and IVF laboratories high quality, innovative and industry leading products.
Healthcare is one of Astorg’s core expertise with over €6.5bn invested in the sector. Astorg invests in global B2B Healthcare leaders, its most recent investments include hg Medical, CordenPharma, OPEN Health, Avania, Cytel, and Clario.
Financial terms for this transaction were not disclosed.
